EED gene polymorphism in patients with colorectal cancer

International Journal of Biological Markers

Volumn 28, Issue 3, 2013, Pages 274-279

  Seo, Geom Seog ^a   Yu, Ji In ^a   Chae, Soo Cheon ^a   Park, Won Cheol ^a   Shin, Sae Ron ^a   Yoo, Seung Taek ^a   Choi, Suck Chei ^a   Lee, Sung Hee ^a  

^a Wonkwang University   (South Korea)

Author keywords

Colorectal cancer; Embryonic ectoderm development gene; Inflammatory bowel disease; Lymph node metastasis

Indexed keywords

EMBRYONIC ECTODERM DEVELOPMENT PROTEIN; EED PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

ADULT; ALLELE; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY;

COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYCOMB REPRESSIVE COMPLEX 2; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84885921669     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/JBM.5000024     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003; 97: 1528-40.
3. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 925-43.
4. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-87.
5. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-17.
6. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-9.
7. Schumacher A, Lichtarge O, Schwartz S, et al. The murine polycomb-group eed and its human orthologue: functional implications of evolutionary conservation. Genomics 1998; 54: 79-88.
8. Sewalt RG, van der Vlag J, Gunster MJ, et al. Characterization of interactions between the mammalian Polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian Polycomb-group protein complexes. Mol Cell Biol 1998; 18: 3586-95.
9. Boyer LA, Plath K, Zeitlinger J, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441: 349-53.
10. Bracken AP, Dietrich N, Pasini D, et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20: 1123-36.
11. Lee TI, Jenner RG, Boyer LA, et al Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125: 301-13.
12. Otte AP, Kwaks TH. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? Curr Opin Genet Dev 2003; 13: 448-54.
13. Kirmizis A, Bartley SM, Kuzmichev A, et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys27. Genes Dev 2004; 18: 1592-605.
14. Kuzmichev A, Jenuwein T, Tempst P, et al. Different Ezh2- containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 2004; 14: 183-93.
15. Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EEDEZH2 complex. Mol Cell 2004; 15: 57-67.
16. Chae SC, Yu JI, Oh GJ, et al. Identification of single nucleotide polymorphisms in the gene and their association with gastrointestinal disorders. Mol Cells 2010; 29: 21-8.
17. Yu JI, Kang IH, Seo GS, et al. Promoter polymorphism of the gene is associated with the susceptibility to ulcerative colitis. Dig Dis Sci 2012; 57: 1537-43.
18. Seo GS. The role of NF-kappaB in colon cancer. Korean J Gastroenterol 2011; 57: 3-7.
19. Yu H, Simons DL, Segall I, et al. PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. PLoS One 2012; 7: e51239.
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. New York, NY: Springer, 2010.
21. Spina C, Saccucci P, Bottini E, et al. ACP1 genetic polymorphism and colon cancer. Cancer Genet Cytogenet 2008; 186: 61-2.
22. Haiman CA, Le Marchand L, Yamamato J, et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 2007; 39: 954-6.
23. Tomlinson I, Webb E, Carvajal-Carmona L, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007; 39: 984-8.
24. Zanke BW, Greenwood CM, Rangrej J, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007; 39: 989-94.
25. Mates IN, Jinga V, Csiki IE, et al. Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage. J Gastrointestin LiverDis 2012; 21: 45-52.
26. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterol 2006; 131: 1700-5.